Trials (Oct 2023)

Frequency of screening and SBT Technique Trial—North American Weaning Collaboration (FAST-NAWC): an update to the protocol and statistical analysis plan

  • Karen E. A. Burns,
  • Myriam Lafrienier-Roula,
  • Nicholas S. Hill,
  • Deborah J. Cook,
  • Andrew J. E. Seely,
  • Bram Rochwerg,
  • Michael Mayette,
  • Frederick D’Aragon,
  • John W. Devlin,
  • Peter Dodek,
  • Maged Tanios,
  • Audrey Gouskos,
  • Alexis F. Turgeon,
  • Pierre Aslanian,
  • Ying Tung Sia,
  • Jeremy R. Beitler,
  • Robert Hyzy,
  • Gerard J. Criner,
  • Elias Baedorf Kassis,
  • Jennifer L. Y. Tsang,
  • Maureen O. Meade,
  • Janice M. Liebler,
  • Jessica T. Y. Wong,
  • Kevin E. Thorpe,
  • For the Canadian Critical Care Trials Group

DOI
https://doi.org/10.1186/s13063-023-07079-5
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 4

Abstract

Read online

Abstract Background This update summarizes key changes made to the protocol for the Frequency of Screening and Spontaneous Breathing Trial (SBT) Technique Trial—North American Weaning Collaborative (FAST-NAWC) trial since the publication of the original protocol. This multicenter, factorial design randomized controlled trial with concealed allocation, will compare the effect of both screening frequency (once vs. at least twice daily) to identify candidates to undergo a SBT and SBT technique [pressure support + positive end-expiratory pressure vs. T-piece] on the time to successful extubation (primary outcome) in 760 critically ill adults who are invasively ventilated for at least 24 h in 20 North American intensive care units. Methods/design Protocols for the pilot, factorial design trial and the full trial were previously published in J Clin Trials ( https://doi.org/10.4172/2167-0870.1000284 ) and Trials (https://doi: 10.1186/s13063-019–3641-8). As planned, participants enrolled in the FAST pilot trial will be included in the report of the full FAST-NAWC trial. In response to the onset of the coronavirus disease of 2019 (COVID-19) pandemic when approximately two thirds of enrollment was complete, we revised the protocol and consent form to include critically ill invasively ventilated patients with COVID-19. We also refined the statistical analysis plan (SAP) to reflect inclusion and reporting of participants with and without COVID-19. This update summarizes the changes made and their rationale and provides a refined SAP for the FAST-NAWC trial. These changes have been finalized before completion of trial follow-up and the commencement of data analysis. Trial registration Clinical Trials.gov NCT02399267.

Keywords